A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Clinical trial NCT06906562 · RECRUITING

Trial details

NCT number: NCT06906562
Sponsor: Sameek Roychowdhury
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Carcinoma Metastatic Pancreatic Carcinoma Stage II Pancreatic Cancer AJCC v8 Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Start date: 2025-08-26
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.